ANTX fundamentals
An in-depth look to AN2 Therapeutics, Inc. operating, investing, and financing activities
ANTX free cash flow for Q3 24 is -12.01 M USD. For 2023, ANTX free cash flow was -53.29 M USD and operating cash flow was -53.29 M USD.
Q3 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: USD
Q3 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
TTM